Published March 24, 2021
We are excited to be backing Gabbi in its $0.5M pre-seed funding, alongside Startup Health and notable angel investors. Gabbi offers a digital health solution that accurately & inclusively predicts a woman's risk for breast cancer and equips her to take action with community support. Gabbi's mission is to decrease delayed diagnosis for women; starting with breast cancer.
Decreasing delayed diagnosis with a consumer-facing risk model that is more accurate and more inclusive than ever before.
Breast cancer is now the most common cancer, ahead of lung and prostate. An average woman in the US has a 13% chance of developing breast cancer; in other words, 1 in 8 American women will have breast cancer. Breast cancer is also the 2nd deadliest cancer across all races/ethnicities, male and female. 85% of women under the age of 50 who are diagnosed with breast cancer experience a delay in diagnosis. The outcome is even more bleak for women of color. “Breast cancer mortality is approximately 40% higher among black women compared with white women” according to the CDC.
Gabbi is on a mission to decrease delayed diagnosis by empowering women to understand their bodies so they can proactively seek the care they need. Gabbi is leveraging AI to accurately predict a woman's risk of breast cancer and equip personalized steps to take action. Existing risk models for women under 35 and women of color are only 53% accurate--Gabbi is for all ethnicities of women over age 21. These risk models are also only used in clinical settings, while Gabbi is the first-ever consumer-facing risk model. Gabbi is the most accurate at 85% AUC compared to other risk models that do not exceed 70% accuracy. Their secret sauce is in their Approach, Inclusivity, and Accuracy.
Plug and Play is one of the most active VCs in Silicon Valley, our goal is to fund the teams that are building the defensible businesses of the future. Join our ecosystem today.